Tegaserod
Rosenbluth Lopez, Helen.
Bol. inf. medicam. (Santiago de Chile)
; 20(2/3): 10-13, dic. 2003. ilus
Artículo en Español | LILACS | ID: lil-390315
Similares
Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial.
In Vivo Evaluation of Almotriptan malate Formulation through Intranasal Route for the Treatment of Migraine: Systematic Development and Pharmacokinetic Assessment.
Pharmacokinetics and bioavailability after intramuscular injection of the 5-HT<sub>1A</sub> serotonin agonist R-8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in domestic goats (Capra aegagrus hircus).
Specifics of Experimental Modeling 8-OH-DPAT-Induced Perseverative Behavior in Mice.
Metabolism of lysergic acid diethylamide (LSD): an update.
Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments.
Tegaserod for the Treatment of Irritable Bowel Syndrome.
Determination of influence of food intake after a single oral dose of mosapride in beagle dogs using nonlinear mixed effect modeling.
Estimation of Circulating Drug Metabolite Exposure in Human Using In Vitro Data and Physiologically Based Pharmacokinetic Modeling: Example of a High Metabolite/Parent Drug Ratio.
Reverse Engineering Drugs: Lorcaserin as an Example.